Migration Biotherapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Migration Biotherapeutics General Information

Description

Developer of a novel medical device designed to improve patient outcomes. The company mimics the behavior of white matter tracks, allowing tumor stem cells to be directed away from healthy brain tissue to extend survival and improve the quality of life for patients, enabling patients to re-center the infiltrating cells in the surgical bed by appearing as a nerve substrate to the relevant tumor cells using our functionalized polycaprolactone fiber.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 45 Bishops Walk
  • Cardiff CF5 2HA
  • Wales, United Kingdom
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Corporate Office
  • 45 Bishops Walk
  • Cardiff CF5 2HA
  • Wales, United Kingdom

Migration Biotherapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Migration Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC Completed Startup
5. Accelerator/Incubator 10-Mar-2023 Completed Startup
4. Seed Round 11-Nov-2022 Cancelled Startup
3. Accelerator/Incubator 30-Sep-2022 Completed Startup
2. Accelerator/Incubator 21-Jan-2022 $56.8K $56.8K Completed Startup
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Migration Biotherapeutics’s complete valuation and funding history, request access »

Migration Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Migration Biotherapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cancer Tech Accelerator Accelerator/Incubator
King's20 Accelerator Accelerator/Incubator Minority
Health Innovation East Midlands Accelerator/Incubator Minority
Pioneer Group Venture Capital Minority
P4 Precision Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Migration Biotherapeutics FAQs

  • When was Migration Biotherapeutics founded?

    Migration Biotherapeutics was founded in 2022.

  • Where is Migration Biotherapeutics headquartered?

    Migration Biotherapeutics is headquartered in Cardiff, United Kingdom.

  • What is the size of Migration Biotherapeutics?

    Migration Biotherapeutics has 3 total employees.

  • What industry is Migration Biotherapeutics in?

    Migration Biotherapeutics’s primary industry is Other Devices and Supplies.

  • Is Migration Biotherapeutics a private or public company?

    Migration Biotherapeutics is a Private company.

  • What is Migration Biotherapeutics’s current revenue?

    The current revenue for Migration Biotherapeutics is .

  • How much funding has Migration Biotherapeutics raised over time?

    Migration Biotherapeutics has raised $141K.

  • Who are Migration Biotherapeutics’s investors?

    Cancer Tech Accelerator, King's20 Accelerator, Health Innovation East Midlands, Pioneer Group, and P4 Precision are 5 of 6 investors who have invested in Migration Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process